Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
about
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesismiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsFunctional RNAs: combined assembly and packaging in VLPs.Using a novel microRNA delivery system to inhibit osteoclastogenesisRNA interference approaches for treatment of HIV-1 infectionIntracellular delivery of messenger RNA by recombinant PP7 virus-like particles carrying low molecular weight protamine.MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.Exogenous microparticles of iron oxide bind to activated endothelial cells but, unlike monocytes, do not trigger an endothelial response.Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Chaperonin-Dendrimer Conjugates for siRNA Delivery.Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex.Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.Caged protein nanoparticles for drug delivery.Delivery and targeting of miRNAs for treating liver fibrosis.The alien replicon: Artificial genetic constructs to direct the synthesis of transmissible self-replicating RNAs: In vivo synthesised heterologous (alien) RNA constructs are capable of initiating self-replication following transmission to the host oDifferent applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Missing link between microRNA and prostate cancer.Plant viruses and bacteriophages for drug delivery in medicine and biotechnology.Delivering Nucleic-Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives.MicroRNAs as mediators of cardiovascular disease: Targets to be manipulatedBiomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous.Monitoring the Disassembly of Virus-like Particles by 19F-NMR.RETRACTED ARTICLE: Cell-specific delivery of messenger RNA and microRNA by recombinant MS2 virus-like particles carrying cell-penetrating peptide.Scaffold-Based microRNA Therapies in Regenerative Medicine and Cancer.Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery.
P2860
Q26783563-DA3B8587-9082-4B28-8A85-993AAD3E0772Q27023295-74EE9B08-8E2E-41F7-A90D-D3339A6C8BE8Q33588746-8FBD3C10-4C73-4CCF-B01D-038DA7BE2F1FQ35585670-4FA53AF2-967D-4A46-8C0D-AB442E5AFF17Q35652119-AA86F44A-1F58-47BE-834E-04B85A5D57C3Q36032757-970807B6-AE24-40C8-A2C1-2E9FDFF0E2EEQ36456019-D94BAD0F-F510-4793-A44E-8E74B0118560Q36915335-60767160-64CF-4165-8DB6-2D83FC7C7E73Q37269190-7C037ACD-82B6-4FCC-9DF3-684FAEEBD083Q37346447-23B2EF0A-1490-4CB3-8E76-29DD0C3B1B44Q37394496-89B17D48-84C5-4BD4-B3A7-C5EB6AC85C82Q37428069-FA0C4296-2274-4F5E-A8DB-F73070464EA4Q37644875-40C25D79-7A27-4270-BF71-6F8D16ECE322Q38123692-021CE213-0041-4EAE-A039-41886BD3C0BFQ38150365-286D26C8-E8C8-4835-BC39-5505E58DFE6BQ38212056-6C05A095-9A36-43DA-BE9F-70A7602F22C4Q38245905-9DC50383-4BF1-49E3-9B38-826F08E41592Q38266429-63444595-5EA1-499C-A403-F619C1CC945BQ38618258-8FB8CDE4-8D65-4E85-BFFB-9BF47435A3F1Q38715316-F9310271-9513-48A3-B187-15022A5D64AFQ38828420-F72006C7-42B2-4ECB-8E74-415E3E338544Q38912667-12D899A7-CB41-41EA-895B-5887DEC6BB61Q39002848-57ACF53E-976D-4974-A330-73B5DE0540BEQ39068831-E0EA3351-0102-4B9D-9DB5-FAAC9385EA1AQ39076542-6B471387-3D3B-42C7-A3BF-662D7E925912Q39456337-D74C29C7-96A3-4B70-901D-AA9B8BC7E93FQ40270477-F00DAD15-36D7-462C-A6B2-EAA211A52B30Q45343688-0F4BF24F-0F25-4DD3-95EB-2716DB38C8DAQ47411533-25600353-940A-4BC1-9333-40048C2CAA53Q54290026-F924E5CA-27D7-41B7-9743-E5CD70B24616
P2860
Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Development of a microRNA deli ...... hage MS2 virus-like particles.
@en
Development of a microRNA deli ...... hage MS2 virus-like particles.
@nl
type
label
Development of a microRNA deli ...... hage MS2 virus-like particles.
@en
Development of a microRNA deli ...... hage MS2 virus-like particles.
@nl
prefLabel
Development of a microRNA deli ...... hage MS2 virus-like particles.
@en
Development of a microRNA deli ...... hage MS2 virus-like particles.
@nl
P2093
P2860
P1433
P1476
Development of a microRNA deli ...... hage MS2 virus-like particles.
@en
P2093
Jinming Li
Lunan Wang
Tingting Jia
Yuan Zhang
P2860
P304
P356
10.1111/J.1742-4658.2012.08512.X
P407
P577
2012-02-23T00:00:00Z